Filing Details
- Accession Number:
- 0001415889-23-008390
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-19 16:04:36
- Reporting Period:
- 2023-05-17
- Accepted Time:
- 2023-05-19 16:04:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1323212 | Eric Pauwels | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-17 | 800 | $58.52 | 64,005 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-17 | 7,248 | $58.50 | 56,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-18 | 788 | $58.71 | 55,969 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $58.53 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
